Calcitriol Capsule — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Calcitriol Capsule (capsule) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Dec 4, 2025.

Shortage details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0093-7353-01
Dosage Form
Capsule
Presentation
Calcitriol, Capsule, .5 ug (NDC 0093-7353-01)
Initial Posting
Dec 4, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.